We focus on medical tourism, digital health, life sciences, and healthcare infrastructure in the UAE and India, aligning with each region’s healthcare vision and government objectives.
The UAE and India offer growth potential and government support for healthcare expansion, innovation, and digital health, making them ideal for impactful investments.
We align with the UAE’s goals by investing in digital health, medical tourism, and life sciences, contributing to its mission of becoming a global healthcare leader by 2071.
India’s projected healthcare growth to US$ 638 billion by 2025, along with government support for healthcare spending, positions it as a key market for our investments.
We invest in hospitals, clinics, telemedicine infrastructure, and specialty facilities, focusing on both urban and rural needs in the UAE and India.
By investing in world-class facilities and services in partnership with global healthcare leaders, we support the UAE’s goal to be a top global medical tourism destination.
India’s cost-effective healthcare and quality services make it attractive for international patients, supporting its growth as a leading medical tourism hub.
We focus on high-demand areas like cardiology, cancer treatment, orthopedic surgeries, and cosmetic treatments, where both countries have strong offerings
Yes, in the UAE, we partner with renowned global institutions to offer patients world-class treatments and services.
By expanding infrastructure, reducing treatment costs, and improving service accessibility, we help India attract more medical tourists globally.
We focus on telemedicine, wearable health tech, AI diagnostics, and cloud-based health data management systems.
Digital health supports the UAE’s vision by increasing healthcare accessibility, reducing costs, and improving patient outcomes.
Our telemedicine investments focus on remote diagnostics, e-consultations, chronic disease management, and telemonitoring systems.
We prioritize investments in secure cloud technologies and comply with local data regulations to ensure patient privacy and data protection.
AI supports preventive care, accurate diagnostics, and cost efficiency, aligning with the UAE and India’s goals for high-quality, accessible healthcare.
We invest in biotechnology, clinical trials, R&D, disease prevention, and treatment innovations, especially in the UAE’s growing life sciences sector.
By funding research and collaborations, we contribute to the UAE’s national life sciences strategy and help position it as a leader in healthcare innovation.
Yes, we collaborate with universities and research institutions in both countries to advance clinical trials, R&D, and medical innovations.
India’s research focuses on biotechnology, clinical trials, and pharmaceutical developments, areas where we invest to support innovation.
We fund clinical trials, support research projects, and invest in life sciences infrastructure, driving healthcare innovation and quality improvement.
We fund education programs, partner with universities, and support talent exchange programs to build a skilled healthcare workforce.
Workforce development is critical to meet rising healthcare demands, improve service quality, and fulfill the long-term healthcare goals of both countries.
Yes, we invest in local healthcare training to build a sustainable talent pool in the UAE and India.
By funding medical education and workforce training programs, we help close the gap in healthcare staffing and meet growing demands.
Our investments create jobs in clinical care, telemedicine, healthcare technology, research, and administration, catering to the needs of both regions.
The healthcare sector has shown resilience and consistent growth, with projected growth rates in both the UAE and India significantly outpacing other sectors.
Yes, we provide detailed ESG reports showing the social and environmental impact of our healthcare investments in both countries.
We manage risk through diversification, regulatory compliance, and close collaboration with reputable healthcare providers.
Key factors include sector growth, government support, technological advancements, and alignment with national healthcare goals.
We invest in medical tourism, digital health, and life sciences to align with the UAE’s vision of becoming a global healthcare leader by 2071.
Our investments support India’s goals of healthcare access, infrastructure growth, and employment in the healthcare sector.
While we don’t have formal partnerships, our alignment with government goals enhances opportunities for support and collaboration.
We work closely with legal advisors and regulatory bodies in both countries to comply with healthcare standards and regulations.
We expand healthcare facilities, especially in underserved regions, and invest in telemedicine to increase healthcare access across India.
We plan to expand into emerging areas like preventive health, advanced diagnostics, and personalized medicine, aligning with technological trends.
Our primary focus remains on the UAE and India, but we continually evaluate opportunities in other regions with aligned healthcare goals.
By investing in telemedicine, digital health, and AI, we support a shift to preventive care, remote consultations, and efficient healthcare delivery.
Key trends include AI in diagnostics, wearable health tech, telemedicine growth, and rising demand for cost-effective healthcare solutions.
Investors can contact us directly, attend webinars, and access our annual reports and whitepapers for detailed information on our healthcare investments.
Epiidosis Investments funds projects across various sectors, including commercial enterprises, tourism, industry, agriculture, energy, education, and healthcare, both locally in the UAE and globally.
To initiate the fundraising process, simply register or log in to the fund seeker dashboard on our platform and follow the step-by-step instructions provided.
For KYC verification, you’ll need to provide identification documents such as a passport, driver’s license, or national ID card, along with any additional company registration documents.
The onboarding and administration fee covers the cost of verifying documents, processing applications, and providing support throughout the initial stages of the fundraising process.
Document verification typically takes a few business days, depending on the volume of applications received.
After successful verification, you’ll proceed to the next phase, which involves signing a service contract and MOU, followed by due diligence and investment agreement signing.
Yes, you’ll have access to your fundraising dashboard, where you can track the progress of your application and receive updates on each stage of the process.
Project assessment and risk underwriting involve evaluating the feasibility, viability, and potential risks associated with the proposed project, considering factors such as market demand, financial projections, and regulatory compliance.
Epiidosis Investments does not provide financial assistance for processing fees; however, we offer support and guidance throughout the fundraising process to help facilitate successful fundraising.
If your project does not pass the risk underwriting process, we will work with you to identify any areas of concern and explore potential solutions to address them.
Funds are deployed to a Special Purpose Vehicle (SPV) established for the project, ensuring proper allocation and management of funds according to the project’s needs.
During the project deployment phase, Epiidosis oversees the setup of the SPV, ensures compliance with regulatory requirements, and provides ongoing support to project stakeholders.
Yes, Epiidosis can create structures to leverage assets and lines of credit, enabling better fund procurement and optimizing financing options for your project.
In the event of challenges or unforeseen circumstances post-fund deployment, Epiidosis works closely with project stakeholders to address issues and explore solutions to mitigate risks.
Epiidosis provides dedicated support from experienced professionals, including account managers and advisors, who are available to assist you at every stage of the fundraising process.
The duration of the fundraising process can vary depending on factors such as document verification, due diligence, and project complexity. Typically, it may take several weeks to months to complete.
Epiidosis funds projects ranging from USD 2 million to USD 150 million, catering to a wide range of project sizes and requirements.
If your project requires additional funding beyond the initial amount raised, we can explore options for additional financing or restructuring to meet the project’s evolving needs.
While changes to the terms of the investment agreement may be possible under certain circumstances, any modifications would need to be mutually agreed upon by all parties involved.
Yes, Epiidosis provides ongoing support and assistance to project stakeholders even after the fundraising process is completed, ensuring continued success and growth of the funded project.
This type of investment allows individuals to leverage their existing listed stocks, debentures, bonds, ETFs, or any other financial holdings as collateral to secure funding. Essentially, it unlocks the value of their investment portfolio without the need to sell the stocks.
Epiidosis provides a platform called InvestcoPortal where individuals can apply for investment using their listed stocks or financial instruments as collateral. The company evaluates the value of the financial asset and extends credit based on this assessment.
By obtaining a financial instrument investment, individuals can access liquidity without liquidating their stock positions or outright selling their financial assets, thus maintaining their investment exposure. Additionally, these investments often come with competitive interest rates and flexible repayment terms.
Individuals seeking loans against stocks benefit from the ability to access funds quickly, often with minimal paperwork. Additionally, they retain ownership of their stocks, allowing them to continue benefiting from potential market appreciation.
Epiidosis Investments LLC offers a streamlined loan application process, competitive interest rates, and personalized service. With a track record of managing diverse portfolios, the company provides borrowers with confidence in their financial transactions.
The funding process typically involves submitting an application, providing details about the listed stocks or other instruments to be used as collateral, and undergoing a valuation process. Once approved, funds are disbursed, and borrowers make repayments according to the agreed-upon terms.
Eligibility criteria vary but generally include individuals with a substantial portfolio of listed stocks or any other instrument. Specific requirements may include the types of stocks accepted as collateral, minimum stock value thresholds, and creditworthiness assessments. Please check our website for complete eligibility requirements.
Interest rates and terms vary depending on factors such as the value of the stocks, bonds, debentures, ETFs, or any other instrument used as collateral, loan amount, and repayment period. Epiidosis provides transparent information on these rates and terms to ensure borrowers understand their obligations.
Epiidosis Investments LLC offers an interactive loan calculator on its website. Users can input details such as the number and value of their stocks to receive an estimate of the loan amount and associated terms.
Epiidosis Investments LLC showcases success stories through real-life use cases on how we solve particular investor problems. On our website, we mention our clients and partners we have worked with. We cannot disclose any particular or detailed information about a case study due to signed NDAs with the respective parties.
Epiidosis Investments LLC provides dedicated support to borrowers throughout the loan application process. This includes assistance with document submission, clarification of eligibility criteria, and addressing any inquiries or concerns.
Epiidosis Investments LLC may offer a newsletter or subscription service to keep interested parties updated on news, promotions, and changes related to investment solutions.
Investment amounts for financial instruments can vary depending on factors such as the value of the listed stocks, bonds, or debentures used as collateral and the borrower’s creditworthiness. Epiidosis Investments LLC offers loan amounts ranging from USD 2 million to USD 150 million, catering to a wide range of financing needs.
Feel free to contact us, we are always ready to assist you with any questions you may have in mind.
